From: anne@tobaccodocuments.org
Date: Sat, 08/04/07
Anne LandmanPosting Date: Saturday, August 4, 2007
FDA Communications Plan
Date of Document: 30 Nov 2000
Collection/Source: Philip Morris
Length: 4 pages
Bates No. 208562714/7143
URL of this Posting: http://tobaccodocuments.org/landman/2085627140-7143.html
Document Images: http://legacy.library.ucsf.edu/tid/gwf31c00
This slide presentation from the public relations company BSMG Worldwide lays
out the elements of Philip Morris' public relations plan to develop FDA
regulation of tobacco products in its favor while striving to minimize any
appearance that the company is driving the effort:
"Enable Philip Morris to play a meaningful role in the development of
legislation to allow FDA regulation of tobacco products"
"Avoid creating the impression that the company is 'dictating the terms' to
Congress and the public.
Quotes
Enable Philip Morris to play a meaningful role in the development of
legislation to allow FDA regulation of tobacco products...
...Activate key supporters and stakeholders to support reasonable
regulation..
...Engage state governments to support regulation as a way of preserving MSA
funds
...Avoid creating the impression that the company is "dictating terms" to
congress and the public
...Emphasize message and YSP [youth smoking prevention] efforts...
Legitimacy phase - present through 1st quarter 2001 --Establish Philip Morris'
legitimacy as a participant in the public debate on FDA regulation
Elements Phase -January 2001 through May 2001 Communicate Philip Morris'
positions on the specific elements of FDA regulation
Passage Phase -June 2001 through June 2002 Active support of passage of
reasonable legislation by Congress.
-----------------------
Company
Philip Morris
Author
BSMG Worldwide
Recipient
Philip Morris
Region
United States
Named Organizations
Chicago Tribune
Commonwealth Club
Congress
Editorial Board
Evergreen
FDA Week
United States Food and Drug Administration
Kennedy School of Government
Mayo Clinic (Located in Rochester, Minnesota)
Has a nicotine dependence center; runs the smoking cessation program at the
Mayo Clinic
National Public Radio
New York Times
Philip Morris
Scripps Howard
Speakers Bureau
Tribune
Washington Post
Washington State School of Public Health
Wall Street Journal
Litigation
Feda/Produced
Named Person
Kessler, David A., M.D., J.D. (FDA Commissioner)
appointed FDA Commissioner by President George Bush in December 1990.
Parrish, Steven C. (PM, Sr. VP, General Counsel)
Partner of industry law firm Shook Hardy and Bacon before going to work for
PM. Was VP of PM Corporate Scientific Affairs in 1990. Defends PM on television.
Type
SPCH, SPEECH, PRESENTATION
REPT, REPORT, OTHER
Subject
FDA regulation of tobacco
--------------------------------------------------------------------------------
This service is created by Anne Landman Tobacco Document Research & Consulting,
sponsored by the Center for Media and Democracy, www.sourcewatch.org and
facilitated by Tobacco Documents Online, www.tobaccodocuments.org
Visit www.tobaccowiki.org, the collaborative online encyclopedia of tobacco
document information!
Anne Landman
TobaccoWiki Editor
P.O. Box 23099
Glade Park, CO 81523-0099
Office (970) 263-9199
Cell (970) 216-9842
anne@sourcewatch.org
www.sourcewatch.org
Subscribe to our free weekly list serve by visiting:
http://www.prwatch.org/cmd/subscribe_sotd.html
Donate now to support independent, public interest reporting:
https://secure.groundspring.org/dn/index.php?id=1118
Collaborate with our public interest investigations:
http://www.sourcewatch.org
| 
